NUTRIENTS AS NOVEL THERAPEUTIC APPROACHES FOR METABOLIC DISTURBANCES IN POLYCYSTIC OVARY SYNDROME

被引：12

作者：

Mansour, Asieh ^{[1
,2
]}

Hosseini, Saeed ^{[2
]}

Larijani, Bagher ^{[2
]}

Mohajeri-Tehrani, Mohammad Reza ^{[2
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Res Inst, Dept Clin Nutr & Dietet, Fac Nutr & Food Technol,Natl Nutr & Food Technol, Tehran, Iran

[2] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran

来源：

EXCLI JOURNAL | 2016年 / 15卷

关键词：

Polycystic ovary syndrome; inositol; isoflavonids; resveratrol; vitamin D; PUFA; D-CHIRO-INOSITOL; RANDOMIZED CLINICAL-TRIAL; VITAMIN-D SUPPLEMENTATION; THECA-INTERSTITIAL CELLS; OXIDATIVE STRESS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OVERWEIGHT PATIENTS; D DEFICIENCY; OBESE WOMEN;

D O I：

10.17179/excli2016-422

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women. This disease is characterized by infertility, menstrual dysfunction, and hyperandrogenism. Also, PCOS is often associated with hyperlipidemia and impaired glucose tolerance, conditions that are associated with cardiovascular disorder, type 2 diabetes, cancer and hypertension. Evidence supports that some nutrients may affect the hormonal and metabolic disturbances of PCOS. Here in this study, we aimed to review the available literature that assessed the nutrients such as inostol, isoflavonids, resveratrol, vitamin D, and PUFA (polyunsaturated fatty acids), known to influence the hormonal and metabolic disturbances of PCOS, along with the strategies and future directions of nutrient supplementations in such patients.

引用

页码：551 / 564

页数：14

共 50 条

[1] Obesity, body composition and metabolic disturbances in polycystic ovary syndrome
Svendsen, Pernille Fog
Nilas, Lisbeth
Norgaard, Kirsten
Jensen, Jens-Erik Beck
Madsbad, Sten
HUMAN REPRODUCTION, 2008, 23 (09) : 2113 - 2121
[2] Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances
Spritzer, Poli Mara
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (02) : 182 - 187
[3] Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome
Wehr, E.
Pilz, S.
Schweighofer, N.
Giuliani, A.
Kopera, D.
Pieber, T. R.
Obermayer-Pietsch, B.
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (04) : 575 - 582
[4] METABOLIC APPROACHES TO THE SUBCLASSIFICATION OF POLYCYSTIC-OVARY-SYNDROME
NORMAN, RJ
MASTERS, SC
HAGUE, W
BENG, C
PANNALL, P
WANG, JX
FERTILITY AND STERILITY, 1995, 63 (02) : 329 - 335
[5] POLYCYSTIC OVARY SYNDROME AND METABOLIC COMORBIDITIES: THERAPEUTIC OPTIONS
De Leo, V.
Musacchio, M. C.
Palermo, V.
Di Sabatino, A.
Morgante, G.
Petraglia, F.
DRUGS OF TODAY, 2009, 45 (10) : 763 - 775
[6] Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome
Wehr, Elisabeth
Moeller, Reinhard
Horejsi, Renate
Giuliani, Albrecht
Kopera, Daisy
Schweighofer, Natascha
Groselj-Strele, Andrea
Pieber, Thomas R.
Obermayer-Pietsch, Barbara
WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (7-8) : 262 - 269
[7] Adrenal Enzyme defects and metabolic Disturbances in Polycystic Ovary syndrome (PCOS).
Mattle, V
Kuntner, B.
Seeber, B.
Witsch-Baumgartner, M.
Kraus-Kinsky, E.
Schulze, E.
Wildt, L.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 768 - 768
[8] Abnormal aminotransferase levels are associated with metabolic disturbances in polycystic ovary syndrome
Wehr, Elisabeth
Giuliani, Albrecht
Trauner, Michael
Pieber, Barbara
Obermayer-Pietsch, Barbara
WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A20 - A21
[9] Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
Mastnak, Lara
Herman, Rok
Ferjan, Simona
Janez, Andrej
Jensterle, Mojca
LIFE-BASEL, 2023, 13 (11):
[10] The polycystic ovary syndrome - Pathogenesis, metabolic implications, and therapeutic approach
DiamantiKandarakis, E
ADOLESCENT GYNECOLOGY AND ENDOCRINOLOGY: BASIC AND CLINICAL ASPECTS, 1997, 816 : 177 - 193

← 1 2 3 4 5 →